Europe Infectious Disease Therapeutics Market - By Disease Type: Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections; By Drug Type: Antibiotics, Antivirals, Antifungals, Antiprotozoals, Others; By End-user: Hospitals, Clinics, Research Institutes, Homecare; By Country: Germany, United Kingdom, France, Spain, Italy, Russia, Switzerland, Netherlands, Denmark and Rest of Europe
8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.2 Europe Infectious Disease Therapeutics Market - Opportunity Analysis Index,
By Disease Type,
By Drug Type,
By End-user,
and Region, 2024 - 2031
9. Europe Europe Infectious Disease Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.1.1 Bacterial Infections
9.1.2 Viral Infections
9.1.3 Fungal Infections
9.1.4 Parasitic Infections
9.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.2.1 Antibiotics
9.2.2 Antivirals
9.2.3 Antifungals
9.2.4 Antiprotozoals
9.2.5 Others
9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Research Institutes
9.3.4 Homecare
9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.4.1 Germany
9.4.2 United Kingdom
9.4.3 France
9.4.4 Spain
9.4.5 Italy
9.4.6 Russia
9.4.7 Netherlands
9.4.8 Poland
9.4.9 Rest of Europe
9.5 Europe
Europe Infectious Disease Therapeutics Market – Opportunity Analysis Index,
By Disease Type,
By Drug Type,
By End-user,
and Country, 2024 - 2031
9.6 Regional Trends Analysis
9.7 Europe Europe Infectious Disease Therapeutics Market Research Report - Company Profiles
9.7.1 Company 1 (Germany)
9.7.2 Company 2 (United Kingdom)
9.7.3 Company 3 (United Kingdom)
10. Competition Landscape
10.1 Strategic Dashboard of Top Market Players
10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
10.2.1 Gilead Sciences Inc.
10.2.2 GlaxoSmithKline plc
10.2.3 Merck & Co. Inc.
10.2.4 Pfizer Inc.
10.2.5 Johnson & Johnson
11. Data Collection Method and Research Approach 12. Principal Presumptions and Acronyms
Methodology & Credibility
Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.